Literature DB >> 12117604

MRI measurement of blood-brain barrier permeability following spontaneous reperfusion in the starch microsphere model of ischemia.

Neil G Harris1, Victoria Gauden, Paul A Fraser, Stephen R Williams, Geoff J M Parker.   

Abstract

Quantification of the acute increases in blood-brain barrier (BBB) permeability that occur subsequent to experimental ischemic injury has been limited to single time-point, invasive methodologies. Although permeability can be qualitatively assessed to visualise regional changes during sequential studies on the same animal using contrast-enhanced magnetic resonance imaging (MRI), quantitative information on the magnitude of change is required to compare barrier function during sequential studies on the same animal or between different animals. Recently, improvements in MRI tracer kinetic models and in MR hardware design mean that an estimate of permeability in vivo can now be obtained with acceptable accuracy and precision. We report here the use of such methods to study acute changes following spontaneous reperfusion in an animal model of ischemia. We have obtained estimates of BBB permeability following spontaneous reperfusion, subsequent to forebrain ischemia by unilateral carotid injection of starch microspheres in the rat. T2*-weighted and diffusion-trace imaging were used to monitor the initial reduction in CBF and the time-course of ischemia, respectively. Following reperfusion, an intraveneous bolus of dimeglumine gadopentetate (Gd-DTPA) and horseradish peroxidase (HRP) was given during a continuous acquisition of T1 maps with a 48 s temporal resolution. Permeability maps were constructed using a 4-compartment model; K(trans), the permeability-surface area product of the capillary walls was estimated to be 9.2 +/- 0.6 x 10(-4) min(-1) in the cortex. Visualisation of the regional extent of HRP extravasation on histological sections following termination of the experiment demonstrated very little correspondence to the region of Gd-DTPA leakage. Quantitative MRI assessment of BBB permeability following ischemia-reperfusion is consistent with published values obtained by invasive methods. Differences between Gd-DTPA-enhancement and HRP may reflect differences in the molecular size of the tracers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117604     DOI: 10.1016/s0730-725x(02)00498-8

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  5 in total

1.  MRI measurement of blood-brain barrier transport with a rapid acquisition refocused echo (RARE) method.

Authors:  Jeffrey H Walton; Kit Fai Ng; Steven E Anderson; John C Rutledge
Journal:  Biochem Biophys Res Commun       Date:  2015-05-19       Impact factor: 3.575

2.  The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies.

Authors:  Arnar Astradsson; Bruce G Jenkins; Ji-Kyung Choi; Penelope J Hallett; Michele A Levesque; Jack S McDowell; Anna-Liisa Brownell; Roger D Spealman; Ole Isacson
Journal:  Neurobiol Dis       Date:  2009-06-06       Impact factor: 5.996

3.  Effects of maternal treatment with corticosteroids on tight junction protein expression in the cerebral cortex of the ovine fetus with and without exposure to in utero brain ischemia.

Authors:  Shadi N Malaeb; Grazyna B Sadowska; Barbara S Stonestreet
Journal:  Brain Res       Date:  2007-06-02       Impact factor: 3.252

4.  Dynamic contrast-enhanced magnetic resonance imaging parameters independent of baseline T10 values.

Authors:  Jun-Yu Guo; Wilburn E Reddick; Mark A Rosen; Hee Kwon Song
Journal:  Magn Reson Imaging       Date:  2009-06-25       Impact factor: 2.546

5.  Intra-arterial delivery of triolein emulsion increases vascular permeability in skeletal muscles of rabbits.

Authors:  Hak Jin Kim; Yong Woo Kim; In Sook Lee; Jong Woon Song; Yeon Joo Jeong; Seon Hee Choi; Kyung Un Choi; Kuen Tak Suh; Byung Mann Cho
Journal:  Acta Vet Scand       Date:  2009-07-16       Impact factor: 1.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.